Literature DB >> 8021602

Characterization of immune responses to baculovirus-expressed equine herpesvirus type 1 glycoproteins D and H in a murine model.

D Tewari1, J M Whalley, D N Love, H J Field.   

Abstract

A murine intranasal infection model for equine herpesvirus type 1 (EHV-1) was used to evaluate immune responses following immunization with insect cells infected by baculoviruses that express EHV-1 glycoproteins. Baculovirus recombinant glycoprotein D (gD) and gH both induced serum antibodies to EHV-1 when measured by ELISA. The gD recombinant also produced a neutralizing antibody response. Protective immunity, determined by accelerated clearance of virus from the target organs in the respiratory tract, was demonstrated in mice immunized with a baculovirus recombinant expressing gD. In addition to the serological response, evidence is presented which shows that cell-mediated responses also play an important role in protection. Both recombinants induced delayed-type hypersensitivity and lymphoproliferation to EHV-1 antigen. The protective effects of T cells were confirmed by adoptive transfer of spleen cells from baculovirus gD-immunized donors to recipients that were challenged with live EHV-1. Depletion of either CD4- or CD8-bearing cells from the gD-immunized donors reduced the ability of the recipients to clear virus from the target organs, although depletion of CD4 cells had a more marked effect.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8021602     DOI: 10.1099/0022-1317-75-7-1735

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  7 in total

1.  Immunization with Attenuated Equine Herpesvirus 1 Strain KyA Induces Innate Immune Responses That Protect Mice from Lethal Challenge.

Authors:  Seong K Kim; Akhalesh K Shakya; Dennis J O'Callaghan
Journal:  J Virol       Date:  2016-08-26       Impact factor: 5.103

2.  Baculovirus-expressed nonstructural protein NS2 of bluetongue virus induces a cytotoxic T-cell response in mice which affords partial protection.

Authors:  L D Jones; T Williams; D Bishop; P Roy
Journal:  Clin Diagn Lab Immunol       Date:  1997-05

3.  Expression and characterization of equine herpesvirus 1 glycoprotein D in mammalian cell lines.

Authors:  J E Wellington; G L Lawrence; D N Love; J M Whalley
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

4.  Characterization of the cytolytic T-lymphocyte response to a candidate vaccine strain of equine herpesvirus 1 in CBA mice.

Authors:  P M Smith; Y Zhang; S R Jennings; D J O'Callaghan
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

5.  Expression and characterisation of equine herpesvirus 1 glycoprotein H using a recombinant baculovirus.

Authors:  E M McGowan; M B Hayden; S J Edwards; D Pye; D N Love; J M Whalley
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

6.  Immunization with glycoprotein C of equine herpesvirus-1 is associated with accelerated virus clearance in a murine model.

Authors:  D Tewari; S V Nair; M C De Ungria; G L Lawrence; M Hayden; D N Love; H J Field; J M Whalley
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

7.  Comparison of efficacies of famciclovir and valaciclovir against herpes simplex virus type 1 in a murine immunosuppression model.

Authors:  H J Field; D Tewari; D Sutton; A M Thackray
Journal:  Antimicrob Agents Chemother       Date:  1995-05       Impact factor: 5.191

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.